Current Management of In-Stent Restenosis
Korean Circulation Journal
; : 337-349, 2018.
Article
in En
| WPRIM
| ID: wpr-759383
Responsible library:
WPRO
ABSTRACT
Despite the advent of the drug-eluting stents (DES) and improved stent design, in-stent restenosis (ISR) remains a challenging problem. The currently available options for treatment of ISR include angioplasty alone, repeat stenting with DES or drug-coated balloons. Several recent studies have compared the available options for treating ISR in an attempt to identify the preferred therapeutic strategy. In this review, we will discuss the currently available therapeutic strategies for the management of patients with ISR and the evidence supporting their use.
Key words
Full text:
1
Database:
WPRIM
Main subject:
Stents
/
Angioplasty
/
Drug-Eluting Stents
Limits:
Humans
Language:
En
Journal:
Korean Circulation Journal
Year:
2018
Document type:
Article